Biotech firm moved to the Netherlands to make money: "There is a general problem in Europe, but for us the solution was in the Netherlands"

Dutch venture funds are investing millions into Danish biotech companies and are encouraging Danish businesses to look Southwest in their hunt for financing. Allero Therapeutics moved their business to Holland for this reason.

Emil Pot is CEO of Allero Therapeutics, which he co-founded alongside two former ALK executives, Poul Sørensen and Flemming Steen Jensen. Allero has just moved to the Netherlands to secure an investment. Photo: Foto: NLO / PR

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Related articles